NCT05779917View on ClinicalTrials.gov

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

March 10, 2029

Study Completion Date

March 10, 2036

Conditions
Pancreas CancerCAR-T Cell TherapyMesothelinSolid Tumor, Adult
Interventions
BIOLOGICAL

CAR-T cells

Transfer CAR-T cells into patients for anti-ancer therapy.

Trial Locations (1)

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

Fapon Biotherapy Inc.

UNKNOWN

lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER